Topics

Companies Related to "Propofol and Dexmedetomidine on Inflammation" [Most Relevant Company Matches] RSS

07:18 EST 19th February 2020 | BioPortfolio

Here are the most relevant search results for "Propofol and Dexmedetomidine on Inflammation" found in our extensive corporate database of over 50,000 company records.

Showing "Propofol Dexmedetomidine Inflammation" Companies 1–25 of 269

Relevant

Aerocrine Inc

Aerocrine is a clinically based medical, technical company with headquarters in Stockholm, Sweden. It was founded in 1997 by scientists at the Karolinska Institute that first identified Nitric Oxide (NO) as a marker of inflammation. Aerocrine’s initial commitment is to develop NO analysis for asthma. The company holds a comprehensive patent portfolio in prioritized markets such as the European U...


CytoPherx, Inc.

CytoPherx was founded in July 2007 and is headquartered in Ann Arbor, Michigan. It is a venture backed, clinical stage medical device company addressing inflammation-based diseases and conditions. The company’s products are custom configurations of a proprietary selective cytopheresis-based inflammation modulating system.

American Society of Anesthesiologists

physicians providing professional anesthesia care, does not know the specific circumstances surrounding Michael Jackson's death. However, the ASA unequivocally maintains that Diprivan, or its generic name Propofol, is a drug meant only for use in a medical setting by professionals trained in the provision of general anesthesia. Though the drug is often used for procedures requiring sedation, patie...


Reata Pharmaceuticals, Inc.

Reata Pharmaceuticals is the leader in discovering and developing novel, oral anti-inflammatory drugs that activate Nrf2, the primary regulator of cellular antioxidant and detoxification enzymes. Activation of this important biological target protects against a broad range of diseases associated with inflammation and oxidative stress. Reata is developing b...

Probably Relevant

VIA Pharmaceuticals, Inc.

VIA Pharmaceuticals, Inc. is a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease. VIA's lead candidate, VIA-2291, targets a significant unmet medical need: reducing inflammation in plaque, which is an underlying cause of atherosclerosis and its complications, including heart attack and stroke. In addition, VIA's pipeline of dr...

Airway Therapeutics, Inc.

Airway Therapeutics, based in Cincinnati, OH, is a biopharmaceutical company developing a new class of biologics to break the injury cycle of inflammation for patients with respiratory and inflammatory diseases, beginning with the most vulnerable populations. The company is advancing the novel recombinant human protein rhSP-D, an engineered version of an endogenous protein that reduces inflammati...

Synedgen Inc.

Synedgen Inc. is developing a new class of drugs with the ability to suppress inflammation, reduce infection and improve healing in the gastrointestinal tract and pulmonary tree and to reduce damage and inflammation due to chemical, radiological or physical damage using the science of glycomics - the study of complex sugar structure and function. Synedgen ...

PlaqueTec Ltd.

PlaqueTec offers a first-of-its-kind catheter technology for cardiologists to routinely assess inflammation in the coronary artery, and better understand residual inflammatory risk. It has been proven to detect inflammatory molecules across the site of coronary artery disease (CAD), and can discriminate between patients with greater and lesser levels of co...

Lev Pharmaceuticals

We are a biopharmaceutical company focused on developing and commercializing therapeutic products for the treatment of inflammatory diseases. Our product candidates are based on C1-esterase inhibitor (C1-INH), a human plasma protein that mediates inflammation and is potentially applicable as a treatment for a range of medical indications. We initiated a Phase III clinical trial of our lead product...

Calyx Therapeutics

Calyx Therapeutics uses novel methods to isolate the biologically active molecule from natural plant and animal extracts with demonstrated clinical activity in humans. The company determines the chemical structure of the isolated compound and develops small-molecule analogs for pharmaceutical applications. Calyx is pursuing drug discovery efforts in the areas of diabetes, inflammation and allerg...

Novosom AG

Novosom AG has solved the major obstacle towards DNA therapeutics: Delivery of the therapeutic principle towards the cell interior. Novosom and its partners develop unique DNA based therapeutics in inflammation, oncology and liver diseases. In addition, the company is developing its own pipeline in autoimmune diseases. In 2007, the company plans to file two INDs with partners (oncology and liver d...

InSite Vision Inc.

InSite Vision is advancing new specialty ophthalmic products for the treatment of diseases affecting the front and back of the eye. The company has two commercial products based on its innovative DuraSite® platform approved for the treatment of bacterial eye infections, AzaSite® (azithromycin ophthalmic solution) 1%, marketed in the U.S. by Akorn, In...

Aerocrine, Inc.

Aerocrine AB is a medical technology company focused on the improved management and care of patients with inflammatory airway diseases. The pioneer and leader in the technology to monitor and manage airway inflammation, Aerocrine markets NIOX MINO® and NIOX® Flex. Both products enable the fast and reliable measurement of airway inflammation and may t...

CoDa Therapeutics, Inc.

CoDa Therapeutics is a clinical stage biotechnology company focused on developing novel targeted therapies that address major unmet medical needs in inflammation, wound-healing and tissue repair. The company is pioneering a new field of science: gap junction modulation, using a new class of therapeutics that can modulate wound responses and reduce inflammation. CoDa has two open INDs and has comp...

Aerocrine Inc.

Aerocrine AB is a medical technology company focused on the improved management and care of patients with inflammatory airway diseases. As the pioneer and leader in technology to monitor and manage airway inflammation, Aerocrine markets NIOX MINO® and NIOX Flex®. Both products enable fast and reliable management of airway inflammation and may therefo...

NicOx S.A

NicOx is a product-driven biopharmaceutical company dedicated to the development of nitric oxide-donating drugs to meet unmet medical needs.NicOx is targeting the therapeutic areas of inflammation and cardiovascular disease.The Company’s resources are focused on its two lead compounds in late stage development for the treatment of osteoarthritis and Peripheral Arterial Obstructive Disease (PAOD)...

Colby Pharmaceutical Company

Colby is a privately held company based in Madison, WI and San Jose, CA. Colby is developing new oral small molecule signal transduction modulator drugs and immune modulator biopharmaceuticals for cancer, chronic inflammation, pain, infectious diseases, and neurodegenerative diseases. Colby’s lead small molecule candidates have unique mechanisms of ac...

Regeneron

Regeneron has several product candidates progressing through all stages of human clinical trials, for the potential treatment of a diverse set of diseases, including cancer, eye diseases, and inflammation.Regeneron is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic medicines for the treatment of serious medical conditions. Regeneron has therapeutic ca...

TetraLogic Pharmaceuticals

TetraLogic Pharmaceuticals is a privately held biopharmaceutical company that discovers and develops small molecule drugs that modulate programmed cell death pathways to treat debilitating diseases and conditions. The Company’s SMAC mimetics neutralize critical blocks in the apoptosis pathway to destroy cancer cells selectively. TetraLogic’s necr...

SPI-BIO

SPI-BIO manufactures and markets immunoassays and reagents dedicated to the research in the field of inflammation, apoptosis, hormonology and also a CRO in assay, pharmacokinetics, imaging studies, HIV, prions.

Aerocrine AB

Aerocrine AB is a medical technology company focused on the improved management and care of patients with inflammatory airway diseases. As the pioneer and leader in the technology to monitor and manage airway inflammation, Aerocrine markets NIOX® Flex and NIOX MINO®. Both products enable fast and reliable management of airway inflammation and may the...

MS Central Support

Multiple Sclerosis a life-long chronic disease. Multiple Sclerosis signifies the following: "Multiple" refers to the many areas of inflammation and demyelination that occurs over time. "Sclerosis" means scarring. MS is an autoimmune disease. In MS, the immune system attacks the body's myelin. Myelin is a fatty protein that acts as an insulating matter for nerves. When myelin becomes damaged (demye...

Conatus Pharmaceuticals

Conatus Pharmaceuticals was founded by the executive management team of Idun Pharmaceuticals in July 2005 following the successful sale of Idun to Pfizer. At Idun, the Conatus team pioneered the science of apoptosis and the clinical development of pan caspase inhibitors, validating this first-in-class technology. Conatus has well established relationships with key opinion leaders in the fields of ...

Biota Holdings Limited Australia

Biota's mission is to add shareholder value through the discovery and development of new pharmaceuticals for the management of infectious diseases and inflammation.

Alivio Therapeutics

Alivio Therapeutics, an affiliate of PureTech Health (PRTC.L), is pioneering targeted disease immunomodulation to treat a range of chronic and acute inflammatory disorders. Targeted disease immunomodulation involves acting exclusively at the site of inflammation rather than systemically, to minimize impacts on the wider immune system and healthy tissue. To...


More From BioPortfolio on "Propofol and Dexmedetomidine on Inflammation"

Quick Search

Corporate Database Quicklinks